A Randomised, Double Blind Placebo-Controlled study to Investigate the Safety, Tolerability and clinical activity of GSK1070806 in the Treatment of Patients with Moderate-to-Severe Crohn's Disease

Project: Industry

Participants

Short titleA Randomised, Double Blind Placebo-Controlled study to Investigate the Safety, Tolerability and clinical activity of GSK1070806 in the Treatment of Patients with Moderate-to-Severe Crohn's Disease
StatusActive
Effective start/end date1/05/1831/12/21